Although discovered in the early 1930s, much of the biochemistry and molecular biology of human chorionic gonadotrophin (hCG) has only recently been revealed. The sequence was described in 1973 (Bellisario et al. 1973; Carlsen et al. 1973), but the precise secondary and tertiary structures are still unknown. Only in the last 5 years has there been dramatic progress in the understanding of the molecular nature of this hormone. These studies shed light on many clinical aspects of the biology of hCG, including its association with non-trophoblastic epithelial cancers.
Chorionic gonadotrophin is a member of a group of four structurally homologous proteins commonly referred to as the glycoprotein hormones. As the name implies, the hormone protein chains are glycosylated; hCG contains approximately 30% carbohydrate by weight. The other members are luteinizing hormone (LH), follicle-stimulating hormone (FSH) and thyroid-stimulating hormone (TSH). CG differs from the other glycoprotein
Journal of Molecular Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
Sept 2018 onwards | Past Year | Past 30 Days | |
---|---|---|---|
Full Text Views | 0 | 0 | 0 |
PDF Downloads | 1 | 1 | 0 |